{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:04:38Z","timestamp":1791576278204,"version":"4.3.4"},"reference-count":50,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Seborrheic dermatitis (SD) is a relapsing inflammatory skin disorder that affects the seborrheic areas of the body. Its etiology is not completely elucidated; however, the link between disease exacerbations and the proliferation of Malassezia spp., along with the good response to antifungal agents, indicate the role of fungi in its pathophysiology. Sertaconazole nitrate is a relatively new imidazole antifungal agent with a particular structure, consisting in a benzothiophene ring similar to the indole ring of tryptophan, and it acts mainly through the inhibition of ergosterol synthesis and the formation of pores in the fungal cell membrane. The aim of our study was to evaluate the efficiency of sertaconazole 2% cream compared with other topical treatments in patients with SD. We performed an extensive literature search by browsing the PubMed database with the keyword combination \u201csertaconazole AND seborrheic dermatitis AND clinical trial\u201d, which retrieved eight controlled clinical trials evaluating the effects of sertaconazole in SD. All of the clinical trials included a standard scoring index (SI). At 28 days since the beginning of the treatment, the sertaconazole regimen was associated with a significantly higher percentage of patients with mild SI and a lower percentage of patients with moderate or severe SI (odds ratio 0.51) than the other investigated treatments\u2014hydrocortisone, ketoconazole, clotrimazole, metronidazole, pimecrolimus, and tacrolimus (odds ratio 1.95). In conclusion, treatment with sertaconazole 2% cream may represent an efficient alternative therapy for patients with SD.<\/jats:p>","DOI":"10.3390\/jpm12091540","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T21:47:27Z","timestamp":1663624047000},"page":"1540","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A Meta-Analysis on the Effectiveness of Sertaconazole 2% Cream Compared with Other Topical Therapies for Seborrheic Dermatitis"],"prefix":"10.3390","volume":"12","author":[{"given":"Simona","family":"Georgescu","sequence":"first","affiliation":[{"name":"Department of Dermatology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Department of Dermatology, \u201cVictor Babes\u201d Clinical Hospital for Infectious Diseases, 030303 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mitran","sequence":"additional","affiliation":[{"name":"Department of Microbiology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madalina","family":"Mitran","sequence":"additional","affiliation":[{"name":"Department of Microbiology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Amuzescu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, \u201cVictor Babes\u201d Clinical Hospital for Infectious Diseases, 030303 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Matei","sequence":"additional","affiliation":[{"name":"Department of Dermatology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4983-7648","authenticated-orcid":false,"given":"Mircea","family":"Tampa","sequence":"additional","affiliation":[{"name":"Department of Dermatology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Department of Dermatology, \u201cVictor Babes\u201d Clinical Hospital for Infectious Diseases, 030303 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/jdv.14704","article-title":"The Genetic Basis of Seborrhoeic Dermatitis: A Review","volume":"32","author":"Karakadze","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/exd.14450","article-title":"Skin Microbiome Alterations in Seborrheic Dermatitis and Dandruff: A Systematic Review","volume":"30","author":"Tao","year":"2021","journal-title":"Exp. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/exd.14006","article-title":"Seborrheic Dermatitis\u2014Looking beyond Malassezia","volume":"28","author":"Wikramanayake","year":"2019","journal-title":"Exp. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.clindermatol.2013.01.001","article-title":"Seborrheic Dermatitis: Etiology, Risk Factors, and Treatments: Facts and controversies","volume":"31","author":"Dessinioti","year":"2013","journal-title":"Clin. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Mitran, M.I., Nicolae, I., Tampa, M., Mitran, C.I., Caruntu, C., Sarbu, M.I., Ene, C.D., Matei, C., Georgescu, S.R., and Popa, M.I. (2019). Reactive Carbonyl Species as Potential Pro-Oxidant Factors Involved in Lichen Planus Pathogenesis. Metabolites, 9.","DOI":"10.3390\/metabo9100213"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Nakai, K., and Tsuruta, D. (2021). What Are Reactive Oxygen Species, Free Radicals, and Oxidative Stress in Skin Diseases?. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221910799"},{"key":"ref_7","first-page":"S9","article-title":"Oxidative Stress and Its Impact on Skin, Scalp and Hair","volume":"43","year":"2021","journal-title":"Int. J. Cosmet. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/sjmms.sjmms_50_19","article-title":"Dynamic Thiol\/Disulfide Balance in Patients with Seborrheic Dermatitis: A Case-Control Study","volume":"8","author":"Emre","year":"2020","journal-title":"Saudi J. Med. Med. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.37358\/RC.17.1.5385","article-title":"Vitamin C and Thiobarbituric Acid Reactive Substances (TBARS) in Psoriasis Vulgaris Related to Psoriasis Area Severity Index (PASI)","volume":"68","author":"Tampa","year":"2017","journal-title":"Rev. Chim."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fcimb.2020.00112","article-title":"Malassezia-Associated Skin Diseases, the Use of Diagnostics and Treatment","volume":"10","author":"Saunte","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_11","first-page":"451","article-title":"Note Sur Le Champignon Du Pityriasis Simple","volume":"1","author":"Malassez","year":"1874","journal-title":"Arch. Physiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e04203","DOI":"10.1016\/j.heliyon.2020.e04203","article-title":"Susceptibilities of Malassezia Strains from Pityriasis Versicolor, Malassezia Folliculitis and Seborrheic Dermatitis to Antifungal Drugs","volume":"6","author":"Wang","year":"2020","journal-title":"Heliyon"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11046-012-9606-z","article-title":"Identification of Malassezia Species in Patients with Seborrheic Dermatitis in China","volume":"175","author":"Zhang","year":"2013","journal-title":"Mycopathologia"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s13555-019-0311-4","article-title":"Novel Non-Steroidal Facial Cream Demonstrates Antifungal and Anti-Inflammatory Properties in Ex Vivo Model for Seborrheic Dermatitis","volume":"9","author":"Granger","year":"2019","journal-title":"Dermatol. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s13555-019-00319-0","article-title":"Topical Non-Pharmacological Treatment for Facial Seborrheic Dermatitis","volume":"9","author":"Hexsel","year":"2019","journal-title":"Dermatol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/exd.14091","article-title":"An Update on the Microbiology, Immunology and Genetics of Seborrheic Dermatitis","volume":"29","author":"Adalsteinsson","year":"2020","journal-title":"Exp. Dermatol."},{"key":"ref_17","first-page":"39","article-title":"Changing Our Microbiome: Probiotics in Dermatology","volume":"182","author":"Yu","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/1348-0421.12398","article-title":"Comprehensive Pyrosequencing Analysis of the Bacterial Microbiota of the Skin of Patients with Seborrheic Dermatitis","volume":"60","author":"Tanaka","year":"2016","journal-title":"Microbiol. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Soares, R.C., Camargo-Penna, P.H., de Moraes, V., De Vecchi, R., Clavaud, C., Breton, L., Braz, A.S., and Paulino, L.C. (2016). Dysbiotic Bacterial and Fungal Communities Not Restricted to Clinically Affected Skin Sites in Dandruff. Front. Cell. Infect. Microbiol., 157.","DOI":"10.3389\/fcimb.2016.00157"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1684\/ejd.2017.3038","article-title":"New Perspectives on Dandruff and Seborrheic Dermatitis: Lessons We Learned from Bacterial and Fungal Skin Microbiota","volume":"27","author":"Paulino","year":"2017","journal-title":"Eur. J. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1586\/eri.13.17","article-title":"Sertaconazole: An Antifungal Agent for the Topical Treatment of Superficial Candidiasis","volume":"11","author":"Giusiano","year":"2013","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1046\/j.1365-4362.2003.01981.x","article-title":"Is Topical Metronidazole Effective in Seborrheic Dermatitis? A Double-blind Study","volume":"42","author":"Koca","year":"2003","journal-title":"Int. J. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst. Rev."},{"key":"ref_25","unstructured":"Cohrane Collaboration (2012). Review Manager (RevMan), version 5.2.3, The Nordic Cochrane Centre. Computer Program."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/ced.15067","article-title":"The Efficacy and Safety of Pimecrolimus 1% Cream vs. Sertaconazole 2% Cream in the Treatment of Patients with Facial Seborrhoeic Dermatitis: A Randomized Blinded Trial","volume":"47","author":"Azizzadeh","year":"2022","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_27","first-page":"25","article-title":"Double Blind Study of Sertaconazole 2% Cream vs. Clotrimazole 1% Cream in Treatment of Seborrheic Dermatitis","volume":"59","author":"Goldust","year":"2013","journal-title":"Ann. Parasitol."},{"key":"ref_28","first-page":"119","article-title":"Clinical Study of Sertaconazole 2% Cream vs. Hydrocortisone 1% Cream in the Treatment of Seborrheic Dermatitis","volume":"59","author":"Goldust","year":"2013","journal-title":"Ann. Parasitol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Goldust, M., Ranjkesh, M.R., Amirinia, M., Golforoushan, F., Rezaee, E., and Rezazadeh Saatlou, M.A. (2013). Sertaconazole 2% Cream versus Hydrocortisone 1% Cream in the Treatment of Seborrheic Dermatitis. J. Dermatolog. Treat., 1\u20133.","DOI":"10.3109\/09546634.2012.755251"},{"key":"ref_30","first-page":"173","article-title":"A Double Blind Study of the Effectiveness of Sertaconazole 2% Cream vs. Metronidazole 1% Gel in the Treatment of Seborrheic Dermatitis","volume":"59","author":"Goldust","year":"2013","journal-title":"Ann. Parasitol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s11845-013-0960-8","article-title":"Treatment of Seborrheic Dermatitis: Comparison of Sertaconazole 2% Cream versus Pimecrolimus 1% Cream","volume":"182","author":"Goldust","year":"2013","journal-title":"Ir. J. Med. Sci."},{"key":"ref_32","first-page":"73","article-title":"Treatment of Seborrheic Dermatitis: The Efficiency of Sertaconazole 2% Cream vs. Tacrolimus 0.03% Cream","volume":"59","author":"Goldust","year":"2013","journal-title":"Ann. Parasitol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Lotti, T., Goldust, M., and Rezaee, E. (2013). Treatment of Seborrheic Dermatitis, Comparison of Sertaconazole 2% Cream versus Ketoconazole 2% Cream. J. Dermatol. Treat., 1\u20133.","DOI":"10.3109\/09546634.2013.777154"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Georgescu, S.R., Mitran, C.I., Mitran, M.I., Matei, C., Popa, G.L., Erel, O., and Tampa, M. (2022). Thiol-Disulfide Homeostasis in Skin Diseases. J. Clin. Med., 11.","DOI":"10.3390\/jcm11061507"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/09546634.2018.1473554","article-title":"Treatment of Seborrheic Dermatitis: A Comprehensive Review","volume":"30","author":"Borda","year":"2019","journal-title":"J. Dermatol. Treat."},{"key":"ref_36","first-page":"44","article-title":"Optimizing Treatment Approaches in Seborrheic Dermatitis","volume":"6","author":"Goldenberg","year":"2013","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jaad.2011.02.032","article-title":"Single-Blind, Randomized Controlled Trial Evaluating the Treatment of Facial Seborrheic Dermatitis with Hydrocortisone 1% Ointment Compared with Tacrolimus 0.1% Ointment in Adults","volume":"67","author":"Papp","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_38","first-page":"CD009446","article-title":"Topical Anti-Inflammatory Agents for Seborrhoeic Dermatitis of the Face or Scalp","volume":"5","author":"Kastarinen","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jaad.2020.09.055","article-title":"Tacrolimus 0.1% versus Ciclopiroxolamine 1% for Maintenance Therapy in Patients with Severe Facial Seborrheic Dermatitis: A Multicenter, Double-Blind, Randomized Controlled Study","volume":"84","author":"Joly","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_40","first-page":"CD008138","article-title":"Topical Antifungals for Seborrhoeic Dermatitis","volume":"5","author":"Okokon","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/jdv.12197","article-title":"Systematic Review of Oral Treatments for Seborrheic Dermatitis","volume":"28","author":"Gupta","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4103\/0253-7613.194850","article-title":"Efficacy and Tolerability of Topical Sertaconazole versus Topical Terbinafine in Localized Dermatophytosis: A Randomized, Observer-Blind, Parallel Group Study","volume":"48","author":"Chatterjee","year":"2016","journal-title":"Indian J. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0020-7292(00)00349-0","article-title":"Sertaconazole in the Treatment of Mycoses: From Dermatology to Gynecology","volume":"71","author":"Torres","year":"2000","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0020-7292(00)00351-9","article-title":"Sertaconazole: Pharmacology of a Gynecological Antifungal Agent","volume":"71","author":"Tarrago","year":"2000","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2165\/00003495-200969030-00009","article-title":"Sertaconazole: A Review of Its Use in the Management of Superficial Mycoses in Dermatology and Gynaecology","volume":"69","author":"Croxtall","year":"2009","journal-title":"Drugs"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00403-006-0679-8","article-title":"Anti-Inflammatory and Anti-Itch Activity of Sertaconazole Nitrate","volume":"298","author":"Liebel","year":"2006","journal-title":"Arch. Dermatol. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1038\/jid.2010.152","article-title":"Induction of Prostaglandin D2 through the P38 MAPK Pathway Is Responsible for the Antipruritic Activity of Sertaconazole Nitrate","volume":"130","author":"Kaur","year":"2010","journal-title":"J. Investig. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/mco2.102","article-title":"Sertaconazole Provokes Proapoptotic Autophagy via Stabilizing TRADD in Nonsmall Cell Lung Cancer Cells","volume":"2","author":"Zhang","year":"2021","journal-title":"MedComm"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3109\/09546634.2013.782384","article-title":"Comparison of Sertaconazole 2% Cream versus Hydrocortisone 1% Ointment in the Treatment of Atopic Dermatitis","volume":"24","author":"Saki","year":"2013","journal-title":"J. Dermatol. Treat."},{"key":"ref_50","first-page":"895","article-title":"An Open-Label Study of the Safety and Efficacy of Sertaconazole Nitrate in the Treatment of Seborrheic Dermatitis","volume":"10","author":"Elewski","year":"2011","journal-title":"J. Drugs Dermatol. JDD"}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/12\/9\/1540\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:34:43Z","timestamp":1760142883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/12\/9\/1540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,19]]},"references-count":50,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["jpm12091540"],"URL":"https:\/\/doi.org\/10.3390\/jpm12091540","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,19]]}}}